Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has The Monkey Pox Testing Market Size Shifted, And What Is the Outlook Through 2034?

The market size for monkey pox testing has seen a consistent growth over the past few years. It is expected to expand from a size of $1.46 billion in 2024 to $1.53 billion in 2025, marking a compound annual growth rate (CAGR) of 4.8%. The historical growth can be linked to factors such as increased funding and initiatives from the government, growing demand for conducting quick tests, enhanced testing capacity, amplified research and development, along with rising public awareness campaigns.

How Much Will the Monkey Pox Testing Market Be Worth in 2029?

The market size for monkey pox testing is projected to experience consistent expansion in the coming years, with a worth estimated to reach $1.81 billion in 2029, in line with a compound annual growth rate (CAGR) of 4.4%. The growth for the projected period can be linked with factors such as escalating healthcare spending, the emergence of point-of-care (POC) tests, the expansion of in-home testing kits, concentration on accessibility and affordability, as well as the enhancement of healthcare infrastructure. Key trends to be expected during the forecast period encompass the incorporation of testing with surveillance systems, digital health tools integration, technological progress, integration into public health systems as well as advancements implemented in diagnostic research.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18817&type=smp

Which is the Largest Company in the Monkey Pox Testing Market?

Major companies operating in the monkey pox testing market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Mayo Clinic Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Sonic Healthcare Limited, bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., Cepheid Inc., Aegis Sciences Corporation, Chembio Diagnostics Inc., Flow Health Inc., SeraCare Life Sciences Inc., BioGX Inc., Applied DNA Sciences Inc., CerTest Biotec S.L., Altona Diagnostics GmbH, Creative Biogene Inc., ACON Biotech (Hangzhou) Co Ltd.

What Are the Main Market Drivers in the Monkey Pox Testing Industry?

The escalating occurrences of monkeypox are anticipated to stimulate the expansion of the monkeypox testing market. Monkeypox is an uncommon disease caused by the monkeypox virus, which is related to the smallpox virus and is part of the orthodox virus genre. A surge in monkeypox cases can be attributed to more frequent human-to-human transmission, international travel, and lower immunity resulting from halted smallpox vaccination schemes. Monkeypox testing enables the early detection of infected individuals, paving the way for prompt treatment and confinement to halt the disease’s propagation. The testing also facilitates the tracking of outbreaks and comprehension of the virus’s transmission dynamics. For instance, the European Centre for Disease Prevention and Control (ECDC), a government agency based in Sweden, reported in May 2022 that from January to April 2022, 1,152 suspected monkeypox cases were recorded, associated with 55 fatalities and a case-fatality rate of 4.8%, across 54 health zones in 14 provinces. Moreover, relative to the corresponding period in 2021, there was a rise of 138 suspected instances and 14 deaths, culminating in a higher case-fatality rate of 10.1%. Hence, the upward trend in monkeypox prevalence is fuelling the expansion of the monkeypox testing market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=18817&type=smp

How Is the Monkey Pox Testing Market Segments Structured?

The monkey pox testing market covered in this report is segmented –

1) By Technology: Polymerase Chain Reaction (PCR), Lateral Flow Assay (LFA), Other Technologies

2) By Mode: Laboratory Testing, Point Of Care Testing

3) By End-Use: Hospitals And Clinics, Diagnostic Laboratories, Other End-Uses

Subsegments:

1) By Polymerase Chain Reaction (PCR): Real-Time PCR (qPCR), Reverse Transcription PCR (RT-PCR), Multiplex PCR

2) By Lateral Flow Assay (LFA): Immunochromatographic Lateral Flow Assays, Rapid Antigen Detection Kits

3) By Other Technologies: ELISA (Enzyme-Linked Immunosorbent Assay), CRISPR-based Testing, Serological Tests (Antibody Detection), Nucleic Acid Sequence-Based Amplification (NASBA)

What Strategic Trends Are Transforming the Monkey Pox Testing Market?

Leading companies in the monkey pox testing market are concentrating their efforts on creating advanced diagnostic technologies, like saliva-based monkey pox testing, in order to improve precision, ease, and availability. Utilizing saliva samples to identify the monkeypox virus, saliva-based monkey pox testing offers a novel diagnostic approach. For example, July 2022 saw Flow Health, an American medical lab, introduce a saliva-based (polymerase chain reaction) PCR test for monkeypox, transforming the testing procedure by providing a more convenient, less invasive option for virus detection. This inventive test is distinguished for its high sensitivity and specificity, quick amplification of genetic material, and adaptability for a variety of applications. It enables quantitative assessment of virus concentrations and direct detection of the pathogen and simplifies the collection of samples. A notable benefit is the capability to test individuals before visible lesions occur, a critical component in early detection and curbing virus transmission.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/monkey-pox-testing-global-market-report

Which Global Regions Offer the Highest Growth in the Monkey Pox Testing Market?

North America was the largest region in the monkey pox testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the monkey pox testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18817

This Report Delivers Insight On:

1. How big is the monkey pox testing market, and how is it changing globally?

2. Who are the major companies in the monkey pox testing market, and how are they performing?

3. What are the key opportunities and risks in the monkey pox testing market right now?

4. Which products or customer segments are growing the most in the monkey pox testing market?

5. What factors are helping or slowing down the growth of the monkey pox testing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model